Navigation Links
Reminder: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast
Date:8/12/2009

OMAHA, Neb., Aug. 12 /PRNewswire-FirstCall/ -- Transgenomic Inc. (OTC Bulletin Board: TBIO) announces the following Webcast:

    What:     Transgenomic Inc. Second Quarter 2009 Earnings Release
              Conference Call

    When:     Wednesday, August 12, 2009 @ 5:00 p.m. Eastern

    Where:   http://www.transgenomic.com/events.asp?id=6

    How:      Live over the Internet -- Simply log on to the web at the
              address above.

    Contact:  Investor Relations, 402-452-5400

To access the call via telephone, call 800-894-5910 or 785-424-1052. A replay of the call will be available via telephone until 11:59 pm ET on Wednesday, August 26, 2009. To access, dial 800-388-9064 or 402-220-1116.

About Transgenomic:

Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE((R)) DHPLC Systems, related consumables and assay kits, cytogenetics automated systems, Transgenomic Molecular Clinical Reference Laboratory and Pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please
'/>"/>

SOURCE Transgenomic Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
2. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
3. REMINDER: Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO
4. Reminder: Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
5. Swine Flu a Reminder: Using Hand Sanitizers Like Remi-D Helps Fight Infection
6. Reminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast
7. Transgenomic, Inc. Reports Second Quarter 2007 Results
8. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast
9. Transgenomic, Inc. Forms Scientific Advisory Board
10. Transgenomic Appoints David Pauluzzi to Board of Directors
11. Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 News ... India devoted to genome-based research for ... Genomics (NIBMG) is taking a bite out of oral ... among males in India with the ... solutions from DataDirect Networks (DDN). , To fuel its ...
(Date:9/23/2014)... , Sept. 23, 2014   GenoSpace , ... comprehensive suite of tools to enable the broad use ... announced that it has been awarded Phase I of ... from the National Institutes of Health (NIH) to enable ... Logo - http://photos.prnewswire.com/prnh/20140922/147649 ...
(Date:9/23/2014)... Dr. Williams says, “Find The Black Box ... a three phase process that can lead to the ... would go far beyond anything previously imagined. First everyone ... healthcare.” , “Every effort to improve the quality of ... progress throughout that system because all of the experts ...
(Date:9/22/2014)... who were treated with a statin in the hospital ... likely to survive than those who were not, according ... . This study was conducted by the same researchers ... can improve survival in victims of ischemic stroke., Ischemic ... a blood vessel that blocks blood from reaching areas ...
Breaking Biology Technology:National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 2National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 3National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 4National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 5GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2Statin use during hospitalization for hemorrhagic stroke associated with improved survival 2
... of Allowance of European Patent Application Covering Its Core Natural ... Applications Protection Rights to All Cytokine ... ... (GO), a biotechnology,company dedicated to the discovery and development of improved ...
... 24 Researchers at 28th annual,National Academy ... City this,weekend will present data to help ... breast cancer survivors affected by,"Chemobrain". Chemobrain is ... types of cancer. It is associated with ...
... 24 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:,ONTY) (TSX:ONY), a ... products for the treatment of cancer, today,announced that ... scheduled to present at the 7th Annual BIO ... 2008 at 8:00 a.m. Pacific Time., A ...
Cached Biology Technology:GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology 2GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology 3GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology 4Brain Fitness Program Offers Hope for Breast Cancer Survivors Suffering From 'Chemobrain' 2
(Date:9/23/2014)... a lot greener thanks to a novel technique developed ... solar energy to accelerate tailings pond reclamation efforts by ... light source to treat oil sands process affected water ... and James Bolton have found that using the sunlight ... as efficiently but at a much lower cost. , ...
(Date:9/23/2014)... The National Institutes of Health will award funds to ... Drug Screening program to improve ways of predicting drug ... to refine existing 3-D human tissue chips and combine ... complex functions of the human body. Led by the ... will support 11 institutions at $17 million in 2014 ...
(Date:9/23/2014)... Company has secured $21 million in a Series C ... the Company,s cancer immunotherapy pipeline and advance its lead ... the round, with participation from Majuven and all existing ... Harbinger Venture Capital. , Eureka is engaged in ... mimic the functions of a T cell receptor, a ...
Breaking Biology News(10 mins):Solar energy-driven process could revolutionize oil sands tailings reclamation 2NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4
... This release is available in German . ... disk currently consists of about 3 million magnetic atoms. Researchers ... memory with one bit per molecule. By an electric pulse, ... magnetic state and a low-conductive, non-magnetic state. This novel correlation ...
... in most developing countries to meet the United Nations, ... from hunger by 2015 compared with 1990 levels, according ... and weight, published today in the Lancet . ... improved overall since 1985, one in five infants and ...
... medicine for Parkinson,s disease, by investigating signs of the ... respond to drug treatments. The study was funded by ... skin cells from patients with genetically inherited forms of ... found that neurons derived from individuals with distinct types ...
Cached Biology News:Nature: Molecule changes magnetism and conductance 2Developing world has less than 5 percent chance of meeting UN child hunger target, study estimates 2Developing world has less than 5 percent chance of meeting UN child hunger target, study estimates 3Patient-derived stem cells could improve drug research for Parkinson's 2Patient-derived stem cells could improve drug research for Parkinson's 3Patient-derived stem cells could improve drug research for Parkinson's 4
...
Recalibration of HL-2000-CAL products...
Mature rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and processed within 45 minutes. It is then filtered through gauze, pooled in an ...
Several Pichia pastoris strains are available to allow you to optimize expression and recovery of your protein of interest. Table 1 provides information to help you choose the appropriate strain....
Biology Products: